{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T09:10:12Z","timestamp":1778145012373,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:00:00Z","timestamp":1550016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s10840-019-00518-x","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T02:24:32Z","timestamp":1550024672000},"page":"145-152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Regional differences in patient characteristics and outcomes during uninterrupted anticoagulation with dabigatran versus warfarin in catheter ablation of atrial fibrillation: the RE-CIRCUIT study"],"prefix":"10.1007","volume":"55","author":[{"name":"RE-CIRCUIT\u00ae investigators","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan H.","family":"Hohnloser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh","family":"Calkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Willems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matias","family":"Nordaby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Kleine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branislav","family":"Biss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward P.","family":"Gerstenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,13]]},"reference":[{"key":"518_CR1","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/europace\/eus027","volume":"14","author":"H Calkins","year":"2012","unstructured":"Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS\/EHRA\/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012;14:528\u2013606.","journal-title":"Europace."},{"key":"518_CR2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","volume":"64","author":"CT January","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al. AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64:e1\u201376.","journal-title":"J Am Coll Cardiol."},{"key":"518_CR3","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893\u2013962.","journal-title":"Eur Heart J"},{"key":"518_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.joa.2017.08.001","volume":"33","author":"H Calkins","year":"2017","unstructured":"Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. J Arrhythm. 2017;33:369\u2013409.","journal-title":"J Arrhythm."},{"key":"518_CR5","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1161\/CIRCULATIONAHA.113.006426","volume":"129","author":"L Biase Di","year":"2014","unstructured":"Di Biase L, Burkhardt JD, Santangeli P, Mohanty P, Sanchez JE, Horton R, et al. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the role of coumadin in preventing thromboembolism in atrial fibrillation (AF) patients undergoing catheter ablation (COMPARE) randomized trial. Circulation. 2014;129:2638\u201344.","journal-title":"Circulation."},{"key":"518_CR6","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1701005","volume":"376","author":"H Calkins","year":"2017","unstructured":"Calkins H, Willems S, Gerstenfeld EP, Verma A, Schilling R, Hohnloser SH, et al. Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation. N Engl J Med. 2017;376:1627\u201336.","journal-title":"N Engl J Med."},{"key":"518_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.amjcard.2014.10.002","volume":"115","author":"H Calkins","year":"2015","unstructured":"Calkins H, Gerstenfeld EP, Schilling R, Verma A. Willems S. RECIRCUIT study\u2014randomized evaluation of dabigatran etexilate compared to warfarin in pulmonary vein ablation: assessment of an uninterrupted periprocedural anticoagulation strategy. Am J Cardiol. 2015;115:154\u20135.","journal-title":"Am J Cardiol."},{"key":"518_CR8","unstructured":"ICH. ICH harmonised tripartite guideline. Guideline for good clinical practice E6. website. \n                              http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E6\/E6_R1_Guideline.pdf\n                              \n                           . Accessed 30 Dec 2016."},{"key":"518_CR9","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association Declaration of Helsinki","year":"2013","unstructured":"World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. JAMA. 2013;310:2191\u20134.","journal-title":"JAMA."},{"key":"518_CR10","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1111\/j.0006-341X.1999.01202.x","volume":"55","author":"IS Chan","year":"1999","unstructured":"Chan IS, Zhang Z. Test-based exact confidence intervals for the difference of two binomial proportions. Biometrics. 1999;55:1202\u20139.","journal-title":"Biometrics."},{"key":"518_CR11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/dom.13143","volume":"20","author":"H Caspard","year":"2018","unstructured":"Caspard H, Jabbour S, Hammar N, Fenici P, Sheehan JJ, Kosiborod M. Recent trends in the prevalence of type 2 diabetes and the association with abdominal obesity lead to growing health disparities in the USA: an analysis of the NHANES surveys from 1999 to 2014. Diabetes Obes Metab. 2018;20:667\u201371.","journal-title":"Diabetes Obes Metab."},{"key":"518_CR12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/eurheartj\/ehq394","volume":"32","author":"G Grassi","year":"2011","unstructured":"Grassi G, Cifkova R, Laurent S, Narkiewicz K, Redon J, Farsang C, et al. Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries:results of the BP-CARE study. Eur Heart J. 2011;32:218\u201325.","journal-title":"Eur Heart J."},{"key":"518_CR13","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1097\/HJH.0b013e3283557f4e","volume":"30","author":"T Tomasik","year":"2012","unstructured":"Tomasik T, Windak A, Jozwiak J, Oleszczyk M, Seifert B, Kersnik J, et al. Treatment of hypertension in central and eastern European countries: self-reported practice of primary care physicians. J Hypertens. 2012;30:1671\u20138.","journal-title":"J Hypertens."},{"key":"518_CR14","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1056\/NEJMoa1408288","volume":"372","author":"A Verma","year":"2015","unstructured":"Verma A, Jiang CY, Betts TR, Chen J, Deisenhofer I, Mantovan R, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015;372:1812\u201322.","journal-title":"N Engl J Med."},{"key":"518_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.5853\/jos.2016.00052","volume":"18","author":"OY Bang","year":"2016","unstructured":"Bang OY, Hong KS, Heo JH. Asian patients with stroke plus atrial fibrillation and the dose of non-vitamin K oral anticoagulants. J Stroke. 2016;18:169\u201378.","journal-title":"J Stroke."}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10840-019-00518-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-019-00518-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-019-00518-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T19:15:30Z","timestamp":1581534930000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10840-019-00518-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,13]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["518"],"URL":"https:\/\/doi.org\/10.1007\/s10840-019-00518-x","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,13]]},"assertion":[{"value":"24 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in accordance with the provisions of the Declaration of Helsinki and the International Conference on Harmonisation Good Clinical Practice Guidelines [, ]. The study protocol and procedures were approved by relevant institutional review boards and ethics committees, and all patients provided written informed consent before entering the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"S.H. Hohnloser reports being a consultant, advisor, or speaker for Bayer HealthCare, Bristol-Myers Squibb, Boehringer Ingelheim, Boston Scientific, Cardiome, Forest RI, Gilead, Johnson & Johnson, Medtronic, Otsuka, Pfizer, Portola, Sanofi Aventis, Servier, St. Jude Medical, and Zoll. H. Calkins has received lecture honoraria from Boehringer Ingelheim and Medtronic, and is a consultant to Abbot Medical, AtriCure, and Medtronic. S. Willems has received honoraria as a consultant, advisor, or speaker from Abbott, Bayer HealthCare, Bristol-Myers Squibb, Boehringer Ingelheim, Boston Scientific, Johnson & Johnson, and Medtronic. A. Verma has received research grants from Bayer HealthCare, Boehringer Ingelheim, Daiichi Sankyo, Biotronik, and is a consultant to Biosense Webster and Medtronic. R. Schilling has received research grants from Biosense Webster, Boston Scientific, Medtronic, and St. Jude Medical, and received honoraria and travel sponsorship from Biosense Webster, Boehringer Ingelheim, Boston Scientific, Medtronic, and St. Jude Medical. K. Okumura has received honoraria from Bayer HealthCare, Boehringer Ingelheim, Daiichi Sankyo, Johnson & Johnson, and Medtronic. M. Nordaby and E. Kleine are full-time employees of Boehringer Ingelheim International GmbH. B. Biss is a full-time employee of Boehringer Ingelheim RCV, Vienna, Austria. E.P. Gerstenfeld has received honoraria from Boehringer Ingelheim, a research grant and honoraria from Biosense Webster, and a research grant and honoraria from St. Jude Medical.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}